loratadine has been researched along with Adenocarcinoma, Basal Cell in 1 studies
Loratadine: A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (HISTAMINE H1 ANTAGONISTS) it lacks central nervous system depressing effects such as drowsiness.
loratadine : A benzocycloheptapyridine that is 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine substituted by a chloro group at position 8 and a 1-(ethoxycarbonyl)piperidin-4-ylidene group at position 11. It is a H1-receptor antagonist commonly employed in the treatment of allergic disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JS | 1 |
| Lin, SY | 1 |
| Tso, WL | 1 |
| Yeh, GC | 1 |
| Lee, WS | 1 |
| Tseng, H | 1 |
| Chen, LC | 1 |
| Ho, YS | 1 |
1 other study available for loratadine and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Checkpoint kinase 1-mediated phosphorylation of Cdc25C and bad proteins are involved in antitumor effects of loratadine-induced G2/M phase cell-cycle arrest and apoptosis.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; cdc25 Phosphatases; Cell Cycle; Cell Cycle Protein | 2006 |